PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
23-Mar-2020 Bone Therapeutics receives Clinical Trial Application (CTA) approval for next clinical studies of its two lead candidates BONE THERAPEUTICS
23-Mar-2020 Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy Vaccitech
23-Mar-2020 Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy Vaccitech Limited
23-Mar-2020 Immutep’s partner, EOC Pharma, reports completion of recruitment of phase I study of Efti Immutep
23-Mar-2020 INVESTIGATION REVEALS £21 MILLION NHS BILL FOR AVOIDABLE DEFICIENCIES IN HEART FAILURE BMJ journal
23-Mar-2020 ISA Pharma publishes phase 2 study data in major peer-reviewed journal ISA Pharmaceuticals
23-Mar-2020 Ergomed Announces Provision of Clinical Research Services for COVID-19 Clinical Study Ergomed plc
23-Mar-2020 Britain’s fastest-growing privately-owned pharma companies revealed Alantra
23-Mar-2020 Eureka Therapeutics Completes $45 Million Series E Financing and Enters into Strategic Collaboration with Lyell Immunopharma Eureka Therapeutics
23-Mar-2020 Abeona Therapeutics Announces First Patient Treated in Pivotal Phase III Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa eona Therapeutics
23-Mar-2020 Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine Pfizer
23-Mar-2020 Statement on COVID-19 from the European Cancer Organisation’s Board of Directors: ‘Attention is urgently required to protect cancer patients and preserve Europe’s healthcare professional, scientific and patient societies’ Board of Directors of the European Cancer Organisation
23-Mar-2020 Haselmeier Receives Medical Device Master File Number for D-Flex Product Platform Haselmeier
23-Mar-2020 4D pharma presents additional interim clinical data from combination study for lead oncology candidate 4D
23-Mar-2020 Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine Pfizer
16-Mar-2020 TIKOMED Secures 5M Euro Funding for the Clinical Development of ILB™ and IBSOLVMIR® TIKOMED
16-Mar-2020 BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat BioNTech
16-Mar-2020 GW Pharmaceuticals submits Type II Variation Application to the European Medicines Agency (EMA) to expand the use of EPIDYOLEX®, (cannabidiol) oral solution, for the treatment of seizures associated with Tuberous Sclerosis Complex (TSC) GW Pharmaceuticals plc
16-Mar-2020 Are kidneys targeted by the novel coronavirus? ERA-EDTA
16-Mar-2020 BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China BioNTech SE